CD8A and neoplasm: Following treatment with IR, radioimmunogenic tumor models (i.e., defined as models exhibiting CD8+ T cell-dependent antitumor efficacy following IR) showed activation of cDC1s, whereas poorly radioimmunogenic tumor models (i.e., defined as models exhibiting CD8+ T cell-independent antitumor efficacy following IR) failed to do so [89].